日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The ability of clostridium novyi-NT spores to induce apoptosis via the mitochondrial pathway in mice with HPV-positive cervical cancer tumors derived from the TC-1 cell line

诺维氏梭菌-NT 孢子能够通过线粒体途径诱导源自 TC-1 细胞系的 HPV 阳性宫颈癌肿瘤小鼠细胞凋亡

Behrouz Ebadi Sharafabad, Asghar Abdoli, Parisa Jamour, Azita Dilmaghani

Anti-tumor Effects of Cisplatin Synergist in Combined Treatment with Clostridium novyi-NT Spores Against Hypoxic Microenvironments in a Mouse Model of Cervical Cancer Caused by TC-1 Cell Line

顺铂增效剂联合诺氏梭菌-NT孢子对小鼠TC-1细胞株所致宫颈癌模型缺氧微环境的抗肿瘤作用

Behrouz Ebadi Sharafabad, Asghar Abdoli, Mohammad Panahi, Lida Abdolmohammadi Khiav, Parisa Jamur, Fatemeh Abedi Jafari, Azita Dilmaghani

Safety and potency of BIV1-CovIran inactivated vaccine candidate for SARS-CoV-2: A preclinical study

BIV1-CovIran 灭活候选疫苗对 SARS-CoV-2 的安全性和效力:一项临床前研究

Asghar Abdoli, Reza Aalizadeh, Hossein Aminianfar, Zahra Kianmehr, Ali Teimoori, Ebrahim Azimi, Nabbi Emamipour, Marzieh Eghtedardoost, Vahid Siavashi, Hamidreza Jamshidi, Mohammadreza Hosseinpour, Mohammad Taqavian, Hasan Jalili

Cell type-specific response of colon cancer tumor cell lines to oncolytic HSV-1 virotherapy in hypoxia

缺氧条件下结肠癌肿瘤细胞系对溶瘤 HSV-1 病毒疗法的细胞类型特异性反应

Sara Shayan, Arash Arashkia, Golnaz Bahramali, Asghar Abdoli, Mohammad Sadegh Shams Nosrati, Kayhan Azadmanesh

Potency, toxicity and protection evaluation of PastoCoAd candidate vaccines: Novel preclinical mix and match rAd5 S, rAd5 RBD-N and SOBERANA dimeric-RBD protein.

PastoCoAd候选疫苗的效力、毒性和保护性评估:新型临床前混合匹配rAd5 S、rAd5 RBD-N和SOBERANA二聚体-RBD蛋白

Hassan Pouriayevali Mohammad, Ali Teimoori, Saber Esmaeili, Asghar Abdoli, Delaram Doroud, Mostafa Salehi-Vaziri, Maryam Shahali, Maryam Kadkhodazadeh, Talieh Sabouni, Ali Khosravi Mohammad, Mohammad Panahi, Fereidoon Khoshroo, Anahita Bahmanjeh, Yury Valdes-Balbin, Dagmar Garcia-Rivera, Vicente Verez-Bencomo, Alireza Biglari, Kazem Baesi

SARS-CoV-2: Current trends in emerging variants, pathogenesis, immune responses, potential therapeutic, and vaccine development strategies

SARS-CoV-2:新出现的变异株、发病机制、免疫反应、潜在治疗和疫苗开发策略的当前趋势

Ali Salimi-Jeda, Sina Abbassi, Atieh Mousavizadeh, Maryam Esghaie, Farah Bokharaei-Salim, Farhad Jeddi, Maryam Shafaati, Asghar Abdoli

Combination therapy using human papillomavirus L1/E6/E7 genes and archaeosome: a nanovaccine confer immuneadjuvanting effects to fight cervical cancer

人乳头瘤病毒 L1/E6/E7 基因与古细胞联合治疗:纳米疫苗具有免疫佐剂作用对抗宫颈癌

Hesam Karimi, Hoorieh Soleimanjahi, Asghar Abdoli, Razieh Sadat Banijamali

miR-155 effectively induces apoptosis in K562 Philadelphia positive cell line through upregulation of p27kip1

miR-155 通过上调 p27kip1 有效诱导 K562 费城阳性细胞系细胞凋亡

Mahdi Edalati Fathabad, Morteza Karimipoor, Shaban Alizadeh, Asghar Abdoli, Amir Atashi, Mahtab Sayadi